TABLE 1.
Baseline Demographic and Clinical Characteristics
| Variable | N = 82 |
| Age, yrs | 59.4 ± 11.9 |
| Male (%) | 61 (74.3) |
| Systolic blood pressure, mm Hg | 114.7 ± 17.4 |
| Diastolic blood pressure, mm Hg | 70.1 ± 16.1 |
| Heart rate, b·min−1 | 85.0 ± 21.5 |
| BMI, kg/m2 | 23.5 ± 3.6 |
| NYHA class | |
| II | 22 (26.8) |
| III | 41 (51.3) |
| IV | 19 (21.9) |
| Diseases history, n (%) | |
| Hypertension | 21 (25.6) |
| Diabetes | 14 (17.0) |
| Coronary artery disease | 17 (20.7) |
| MI | 8 (9.7) |
| Atrial fibrillation | 29 (35.3) |
| Therapeutic measure, n (%) | |
| β-blocker | 82 (100) |
| Diuretic | 75 (91.4) |
| Antiplatelet therapy | 17 (20.7) |
| Anticoagulants | 26 (31.7) |
| CRTP/CRTD | 24 (29.2) |
| Baseline laboratory results | |
| eGFR, mL·min−1·1.73 m2 | 76.1 ± 23.5 |
| NT-proBNP, pg/mL | 4181.5 ± 3217.8 |
Values are presented as mean ± SD, number (%), or median (interquartile range).
BMI, body mass index; CRT-D, cardiac resynchronization therapy–defibrillator; CRTP, cardiac resynchronization therapy pacemaker; NT-proBNP, N-terminal pro–B-type natriuretic peptide.